Abstract
Strategies for the synthesis of pure posttranslationally modified proteins or their mimics (for example, glycosylation or prenylation) have been recently developed. In his Perspective, Davis discusses how these strategies are allowing the creation of useful biomolecular probes and how they may offer a potential route to new protein pharmaceuticals.